BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 10908235)

  • 21. Epicardial intimal thickening in transplant coronary artery disease and resistance vessel response to adenosine: a combined intravascular ultrasound and Doppler study.
    Klauss V; Ackermann K; Henneke KH; Spes C; Zeitlmann T; Werner F; Regar E; Rieber J; Uberfuhr P; Reichart B; Theisen K; Mudra H
    Circulation; 1997 Nov; 96(9 Suppl):II-159-64. PubMed ID: 9386092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary thrombolytic therapy: state of the art.
    Marx M; Levin DC
    AJR Am J Roentgenol; 1986 Jul; 147(1):1-8. PubMed ID: 3521234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of translesional hemodynamics: comparison of pressure and flow methods in stenosis assessment in patients with coronary artery disease.
    Di Mario C; Gil R; de Feyter PJ; Schuurbiers JC; Serruys PW
    Cathet Cardiovasc Diagn; 1996 Jun; 38(2):189-201. PubMed ID: 8776528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of refractory no-reflow with intracoronary epinephrine.
    Skelding KA; Goldstein JA; Mehta L; Pica MC; O'Neill WW
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):305-9. PubMed ID: 12410503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of coronary flow reserve in patients with angina pectoris].
    Cai X; Shen WF; Zhang DD
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):686-8, 710-1. PubMed ID: 7866906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effects of intracoronary injection of nitroglycerin on the coronary circulation: evaluation using a Doppler catheter].
    Matsuura Y; Morioka T; Chin W; Kurihara T; Asao M; Hayashi T; Fukushima M; Imaizumi M; Furukawa T
    J Cardiol; 1992; 22(2-3):367-73. PubMed ID: 1339795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of B-type natriuretic peptide (nesiritide) on coronary epicardial arteries, systemic vasculature and microvessels.
    Wu GF; Wykrzykowska JJ; Rana JS; Pinto DS; Gibson CM; Li J; Sellke FW; Laham RJ
    J Invasive Cardiol; 2008 Feb; 20(2):76-80. PubMed ID: 18252972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in human coronary flow reserve after administration of intracoronary diltiazem.
    Vrolix MC; Sionis D; Piessens J; Van Lierde J; Willems JL; De Geest H
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S64-7. PubMed ID: 1725547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
    van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler.
    Ge J; Jeremias A; Rupp A; Abels M; Baumgart D; Liu F; Haude M; Görge G; von Birgelen C; Sack S; Erbel R
    Eur Heart J; 1999 Dec; 20(23):1707-16. PubMed ID: 10562478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of nicorandil on coronary circulation in ischemic region].
    Chen SL; Zhu MZ; Feng XB; Li LS; Zang YM
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):249-53. PubMed ID: 2150905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment.
    Murtagh B; Higano S; Lennon R; Mathew V; Holmes DR; Lerman A
    Am Heart J; 2003 Jul; 146(1):99-105. PubMed ID: 12851614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
    Parham WA; Bouhasin A; Ciaramita JP; Khoukaz S; Herrmann SC; Kern MJ
    Circulation; 2004 Mar; 109(10):1236-43. PubMed ID: 14993141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progressive increase of the coronary flow above peak reactive hyperemia during prolonged intracoronary infusion of adenosine (author's transl)].
    L'Abbate A; Trivella MG; Camici P; Pelosi G; Marzilli M; Ballestra AM; Levantesi D; Taddei L
    G Ital Cardiol; 1981; 11(4):430-40. PubMed ID: 7286516
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasoactive drug infusion: making life easier.
    Kondo K
    Anesthesiology; 1984 Jun; 60(6):617. PubMed ID: 6731930
    [No Abstract]   [Full Text] [Related]  

  • 36. Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters.
    Dal Lin C; Tona F; Osto E
    Int J Endocrinol; 2015; 2015():312848. PubMed ID: 26124827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary microvascular dysfunction in the clinical setting: from mystery to reality.
    Herrmann J; Kaski JC; Lerman A
    Eur Heart J; 2012 Nov; 33(22):2771-2782b. PubMed ID: 22915165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of glyceryl trinitrate and amyl nitrite on pulse wave reflection and augmentation index.
    Greig LD; Leslie SJ; Gibb FW; Tan S; Newby DE; Webb DJ
    Br J Clin Pharmacol; 2005 Mar; 59(3):265-70. PubMed ID: 15752371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive assessment of the coronary circulation: intravascular ultrasound and Doppler.
    Newby DE; Fox KA
    Br J Clin Pharmacol; 2002 Jun; 53(6):561-75. PubMed ID: 12047480
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracoronary infusions and the assessment of coronary blood flow in clinical studies.
    Newby DE
    Heart; 2000 Aug; 84(2):118-20. PubMed ID: 10908235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.